Prognostic value of kappa free light chains determination in first-ever multiple sclerosis relapse
- 1 October 2020
- journal article
- research article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 347, 577355
Abstract
No abstract availableKeywords
Funding Information
- Biogen Idec
- Biogen Idec
- Sanofi Genzyme
- Biogen Idec
- Biogen
- Biogen Idec
- Sanofi Genzyme
This publication has 30 references indexed in Scilit:
- Kappa Free Light Chains: Diagnostic and Prognostic Relevance in MS and CISPLOS ONE, 2014
- Body fluid biomarkers in multiple sclerosisThe Lancet Neurology, 2014
- The clinical course of multiple sclerosis2014
- High levels of cerebrospinal fluid free kappa chains predict conversion to multiple sclerosisClinica Chimica Acta, 2012
- B cells and antibodies in multiple sclerosis pathogenesis and therapyNature Reviews Neurology, 2012
- Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteriaAnnals of Neurology, 2011
- A consensus protocol for the standardization of cerebrospinal fluid collection and biobankingNeurology, 2009
- Clinical and Demographic Predictors of Long-term Disability in Patients With Relapsing-Remitting Multiple SclerosisArchives of Neurology, 2006
- Multiple Sclerosis Severity ScoreNeurology, 2005
- Rating neurologic impairment in multiple sclerosisNeurology, 1983